According to the deal, Sandor will look after the Caldolor regulatory activities and further distribution and sales operations in the territory. Cumberland will continue product formulation, development and
The concomitant therapy contains proton pump inhibitor (lansoprazole, omeprazole, rabeprazole sodium and esomeprazole magnesium hydrate, generic name), amoxicillin hydrate, and either clarithromycin or metronidazole. H. pylori gastritis, thought
Under the transaction, Eisai earns $65m upfront payment in addition to probable milestone-based contingent payments. The new drug application (NDA) for Targretin was transferred to Valeant, which will
The firm has also announced the expansion of its R&D quality systems service for the preclinical (GLP) and clinical (GCP) phases in the development of active ingredients and
Patiromer is a high capacity non-absorbed oral potassium used for the management of elevated serum potassium levels, according to the company. Conducted in two parts, the study’s Part
The new kit will help researchers to prepare high-quality, strand-specific libraries for next-generation sequencing. The kit has been optimized to provide outstanding sequencing performance and uniform coverage of
Under the agreement, Samsung will be responsible for preclinical and clinical development, process development and manufacturing, clinical trials and registration of multiple pre-specified and undisclosed biosimilar candidates. Merck,
As part of the agreement, SCT and NexGen will license their respective technologies to ReNeu under world-wide, royalty-free licenses for the use of NexGen’s FDA-cleared EViTAR line of
The test will be made available to physician clients of Quest Diagnostics in certain regions in the US in March and available nationwide from April 2013. Panorama is
Under the licenses, Cedars-Sinai Medical Center can use Neuralstem’s intellectual property surrounding of spinal cord delivery platform, floating cannula, and method for delivering therapeutic agents. Cedars-Sinai Medical Center
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.